TY - JOUR
T1 - Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab′)2
AU - Aprile, C.
AU - Prati, U.
AU - Saponaro, R.
AU - Roveda, L.
AU - Carena, M.
AU - Gastaldo, L.
PY - 1991
Y1 - 1991
N2 - Thirty-two immunoscintigraphic studies have been performed in 26 patients previously operated upon for rectosigmoid cancer, for an early detection of pelvic recurrence, employing 111In anti-CEA, F(ab′)2. The sensitivity was 1, specificity 0.76 and accuracy 0.84, leading to a positive predictive value of 0.69 and a negative value of 1. The combined use of a non-imaging surgical probe in 6 of the 10 patients who underwent second look surgery, detecting the 111In radioactivity used for RIS, improved diagnostic accuracy, ruling out the presence of tumors in 3 patients with false positive RIS.
AB - Thirty-two immunoscintigraphic studies have been performed in 26 patients previously operated upon for rectosigmoid cancer, for an early detection of pelvic recurrence, employing 111In anti-CEA, F(ab′)2. The sensitivity was 1, specificity 0.76 and accuracy 0.84, leading to a positive predictive value of 0.69 and a negative value of 1. The combined use of a non-imaging surgical probe in 6 of the 10 patients who underwent second look surgery, detecting the 111In radioactivity used for RIS, improved diagnostic accuracy, ruling out the presence of tumors in 3 patients with false positive RIS.
UR - http://www.scopus.com/inward/record.url?scp=44949281913&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44949281913&partnerID=8YFLogxK
U2 - 10.1016/0883-2897(91)90046-N
DO - 10.1016/0883-2897(91)90046-N
M3 - Article
C2 - 2010306
AN - SCOPUS:44949281913
VL - 18
SP - 51
EP - 52
JO - Nuclear Medicine and Biology
JF - Nuclear Medicine and Biology
SN - 0969-8051
IS - 1
ER -